Search research articles
Contact Us
Filters
Showing results (41-50 of 129) with videos related to
Page
of 13
Sort By:
Clinical Colorectal Cancer
|
October 1, 2016
Capecitabine and Oxaliplatin Prior and Concurrent to Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer: Long-Term Outcome
Viviane Hess, Ralph Winterhalder, Roger von Moos, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 24, 2014
Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents
Donald L Patrick, Charles S Cleeland, Roger von Moos, et al.
Onkologie
|
February 23, 2013
A phase I study of the oral platinum agent satraplatin in combination with oral vinorelbine in patients with advanced solid malignancies
Elisa Gallerani, Richard Cathomas, Cristiana Sessa, et al.
Journal of Bone Oncology
|
January 11, 2019
A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe
Jean-Jacques Body, Roger von Moos, Alex Rider, et al.
BMJ Open
|
April 18, 2023
Completion and publication of clinical trials in a cooperative group: a cohort study of trials of the Swiss Group for Clinical Cancer Research (SAKK)
Stefanie Hayoz, Benjamin Kasenda, Annina Lea Schenker, et al.
Journal of Bone Oncology
|
June 13, 2018
Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries
Roger von Moos, Jean-Jacques Body, Alex Rider, et al.
Plos One
|
April 4, 2024
Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer
Tarun Mehra, Judith E Lupatsch, Thibaud Kössler, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 18, 2016
A Cost-Effectiveness Analysis of Nivolumab versus Docetaxel for Advanced Nonsquamous NSCLC Including PD-L1 Testing
Klazien Matter-Walstra, Matthias Schwenkglenks, Stefan Aebi, et al.
Plos One
|
December 12, 2024
Correction: Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer
Tarun Mehra, Judith E Lupatsch, Thibaud Koessler, et al.
Cancer Chemotherapy and Pharmacology
|
October 6, 2017
Phase I study of a chloroquine-gemcitabine combination in patients with metastatic or unresectable pancreatic cancer
Panagiotis Samaras, Marina Tusup, Thi Dan Linh Nguyen-Kim, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 129) with videos related to
Sort By:
Page
of 13
Clinical Colorectal Cancer
|
October 1, 2016
Capecitabine and Oxaliplatin Prior and Concurrent to Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer: Long-Term Outcome
Viviane Hess, Ralph Winterhalder, Roger von Moos, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 24, 2014
Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents
Donald L Patrick, Charles S Cleeland, Roger von Moos, et al.
Onkologie
|
February 23, 2013
A phase I study of the oral platinum agent satraplatin in combination with oral vinorelbine in patients with advanced solid malignancies
Elisa Gallerani, Richard Cathomas, Cristiana Sessa, et al.
Journal of Bone Oncology
|
January 11, 2019
A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe
Jean-Jacques Body, Roger von Moos, Alex Rider, et al.
BMJ Open
|
April 18, 2023
Completion and publication of clinical trials in a cooperative group: a cohort study of trials of the Swiss Group for Clinical Cancer Research (SAKK)
Stefanie Hayoz, Benjamin Kasenda, Annina Lea Schenker, et al.
Journal of Bone Oncology
|
June 13, 2018
Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries
Roger von Moos, Jean-Jacques Body, Alex Rider, et al.
Plos One
|
April 4, 2024
Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer
Tarun Mehra, Judith E Lupatsch, Thibaud Kössler, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 18, 2016
A Cost-Effectiveness Analysis of Nivolumab versus Docetaxel for Advanced Nonsquamous NSCLC Including PD-L1 Testing
Klazien Matter-Walstra, Matthias Schwenkglenks, Stefan Aebi, et al.
Plos One
|
December 12, 2024
Correction: Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer
Tarun Mehra, Judith E Lupatsch, Thibaud Koessler, et al.
Cancer Chemotherapy and Pharmacology
|
October 6, 2017
Phase I study of a chloroquine-gemcitabine combination in patients with metastatic or unresectable pancreatic cancer
Panagiotis Samaras, Marina Tusup, Thi Dan Linh Nguyen-Kim, et al.
Page
of 13